Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-04-06 @ 9:33 AM
Study NCT ID:
NCT07349251
Status:
RECRUITING
Last Update Posted:
2026-01-16
First Post:
2026-01-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Normal Hemostasis Values in Premature Infants
Sponsor:
University Hospital, Strasbourg, France
Organization:
Study Overview
Official Title:
Normal Hemostasis Values in Premature Infants
Status:
RECRUITING
Status Verified Date:
2026-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRHEMO
Brief Summary:
This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: